UK-based Swarm Oncology, a biotech developing T-cell therapies to achieve long-term remission in advanced solid cancers, has announced a strategic partnership with cell and gene therapy-focused ...

Boston, USA-based biotech Nimbus Therapeutics today revealed that, along with partner Eli Lilly, it has achieved a ...

US biotech Regeneron Pharmaceuticals says that its investigational gene therapy DB-OTO showed clinically-meaningful hearing ...

US biotech major Amgen will invest about $200 million this year in its new technology center in southern India.

Florida, USA-based Summit Therapeutics saw its share rise 6.2% to $23.50 pre-market on the news of a clinical trial ...

The US Food and Drug Administration (FDA) has approved label changes for Sublocade (buprenorphine extended-release), ...

Pfizer yesterday revealed that Dr Patrizia Cavazzoni will rejoin the pharma giant as chief medical officer, executive vice ...

The Japanese Ministry of Health, Labor and Welfare (MHLW) in Japan has approved Sarclisa (isatuximab), in combination with ...

South Korean firm Celltrion announced that the European Commission (EC) has granted marketing authorization for Avtozma ...

Danish pharma major Novo Nordisk (NOV: N) has announced the appointment of Sebnem Avsar Tuna (pictured, above) as the new ...

After a significant increase in 2023, Danish regions' expenses for subsidized medicines fell by 4.3% in 2024.

US CNS-focused biopharma firm Axsome Therapeutics today announced that the EMERGE Phase III trial of Symbravo (MoSEIC ...